| Description |
1 online resource (419 p.) |
| Contents |
Cover -- Title Page -- Copyright -- Contents -- Preface -- About the Authors -- Part I Introduction to Viruses -- Chapter 1 Overview of Molecular Biology -- 1.1 Cell Basics -- 1.1.1 Cytoplasm -- 1.1.2 Ribosomes -- 1.1.3 Nucleus -- 1.2 Cell Replication -- 1.2.1 Nucleic Acids -- 1.2.2 DNA Replication -- 1.2.3 RNA Structure and Role -- 1.2.4 Protein Synthesis -- 1.3 Cellular Transport -- 1.3.1 Plasma Membrane -- 1.3.2 Cell Signaling -- 1.4 Immune Defense -- 1.4.1 Innate Immunity -- 1.4.2 Adaptive Immunity -- 1.4.2.1 Humoral Immunity -- 1.4.2.2 Cellular Immunity -- 1.5 Applications |
|
1.6 Chapter Summary -- 1.7 Problems -- References -- Chapter 2 Basics of Virology -- 2.1 Viral Basics and Terminology -- 2.2 Viral Life Cycle -- 2.2.1 Attachment (Connection) -- 2.2.2 Penetration (Entry) -- 2.2.3 Uncoating -- 2.2.4 Replication -- 2.2.5 Assembly -- 2.2.6 Maturation and Release -- 2.3 Virus Structure and Classification -- 2.3.1 DNA Viruses -- 2.3.2 RNA Viruses -- 2.3.3 Reverse Transcription Viruses (Retroviruses) -- 2.4 Viruses in Context of the Tree of Life -- 2.5 Viral Genetics -- 2.5.1 Antigenic Shift -- 2.5.2 Antigenic Drift -- 2.5.3 Phenotypic Mixing -- 2.5.4 Complementation |
|
2.6 Applications -- 2.7 Chapter Summary -- 2.8 Problems -- References -- Chapter 3 Pandemics, Epidemics, and Outbreaks -- 3.1 Human Viral Diseases -- 3.2 Ebola and Marburg Viruses -- 3.2.1 Symptoms -- 3.2.2 Diagnosis -- 3.2.3 Prevention and Treatment -- 3.3 Human Immunodeficiency Disease (HIV) -- 3.3.1 HIV Symptoms -- 3.3.1.1 Stage 1: Acute Infection -- 3.3.1.2 Stage 2: Chronic HIV Infection (Latent Phase) -- 3.3.1.3 Stage 3: Acquired Immunodeficiency Syndrome (AIDS) -- 3.3.2 Diagnosis -- 3.3.3 HIV Prevention and Treatment -- 3.4 Influenza -- 3.4.1 Influenza Symptoms -- 3.4.2 Influenza Diagnosis |
|
3.4.3 Influenza Prevention and Treatment -- 3.4.4 Influenza Pandemics -- 3.5 Coronaviruses -- 3.5.1 Symptoms -- 3.5.1.1 Typical Acute Symptoms -- 3.5.1.2 Post-COVID Conditions -- 3.5.1.3 COVID-19 Multiorgan System Effects (MIS) -- 3.5.2 COVID-19 Diagnosis -- 3.5.3 COVID-19 Prevention and treatment -- 3.6 Current and Emerging Viral Threats -- 3.7 Applications -- 3.8 Chapter Summary -- 3.9 Problems -- References -- Chapter 4 Virus Prevention, Diagnosis, and Treatment -- 4.1 Vaccination Successes and Challenges -- 4.2 Current Vaccine Technology -- 4.2.1 Live-attenuated vaccines |
|
4.2.2 Inactivated vaccines -- 4.2.3 Recombinant Subunit Vaccines -- 4.2.4 Viral Vector Vaccines -- 4.2.5 Messenger RNA (mRNA) Vaccines -- 4.3 U.S.-Approved Vaccines and Requirements -- 4.3.1 Commercially Available Viral Vaccines -- 4.3.2 Vaccination Requirements -- 4.4 Viral Testing and Diagnosis -- 4.4.1 Viral Testing -- 4.4.2 Antibody Testing -- 4.5 Antiviral Treatment Options -- 4.5.1 HIV -- 4.5.1.1 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) -- 4.5.1.2 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) -- 4.5.1.3 Protease Inhibitors (PIs) -- 4.5.1.4 Fusion Inhibitors (FIs) |
| Notes |
Description based upon print version of record |
|
4.5.1.5 Integrase Strand Transfer Inhibitors (INSTIs) |
| Form |
Electronic book
|
| Author |
Theodore, Louis
|
| ISBN |
9781119853145 |
|
1119853141 |
|
1119853168 |
|
9781119853169 |
|
